CT
Click Therapeutics
United States · Healthtech
Click Therapeutics develops physician-prescribed software treatments delivered through smartphones.
Product
Click Therapeutics develops and commercializes prescription digital treatments for patients and clinicians. Its platform combines software, neuroscience and machine learning to deliver structured interventions through a phone.
The company works with pharmaceutical partners on standalone digital treatments and software used alongside medicines. Its product portfolio spans depression, schizophrenia, episodic migraine and type 2 diabetes.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series D | $50M | Boehringer Ingelheim — Participant |